跳至主要内容
临床试验/TCTR20210427009
TCTR20210427009已完成不适用

ong-term renal allograft outcomes of recurrent immunoglobulin A in kidney transplant recipients treating with rituximab

/A0 个研究点目标入组 40 人开始时间: 2021年4月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • Adult kidney transplant recipients age >18 years old with the recurrence of IgAN

排除标准

  • Missing clinical and laboratory data
  • Referring to another hospital
  • Previous treatment with rituximab for any other conditions
  • History of recurrent infection or recurrent bacterial infection unrelated to either rituximab or other treatments for recurrent IgA nephropathy
  • Ongoing use of high-dose corticosteroids (equivalent to 10 mg/day prednisolone)
  • Pre-existing significant systemic or severe illness with expected life- expectancy <6 months before the diagnosis of recurrent IgA nephropathy

研究者

发起方
/A

相似试验

ong-term outcomes of recurrent IgAN treating with... | 临床试验